Alphatec Holdings, Inc. (ATEC) stock

ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 7/30

$7.07+0.01 (+0.14%)

Close on Nov 13, 2026Market cap $1.10BP/E –Yield –

Alphatec EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Alphatec's EV/EBITDA was 86.8× on Nov 11, 2026, against 40.6× a year earlier. Over the last 4 years it ranged from 4.8× to 254.4×, with a median of 23.0×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	86.8×	+35.6
2018	Jul 31, 2018	51.2×	+24.3
2017	Jan 31, 2017	26.9×	−1.9
2016	Dec 30, 2016	28.8×	+23.9
2015	Oct 30, 2015	4.9×	−44.3
2014	Jan 31, 2014	49.2×	+3.2
2013	Dec 31, 2013	46.0×	+29.4
2012	Jan 31, 2012	16.6×	+0.4
2011	Dec 30, 2011	16.3×	–

Where these numbers come from

Parsed from the XBRL in Alphatec's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Aug 25, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATEC.

Compare: ATEC vs OFIX · ATEC vs BVS · ATEC vs GMED · ATEC vs ATRC · ATEC vs CARL

Revenue growth15.3% · median 13.4%

Gross margin71.3% · median 70.9%

Operating margin-3.6% · median 2.9%

Net margin-10.3% · median 2.5%

Company	Revenue	Growth
GMED	$3.14B	+13.4%
ATEC	$839.72M	+15.3%
OFIX	$835.41M	+2.1%
ATRC	$589.80M	+13.8%
BVS	$585.64M	+3.9%
CARL	$71.78M	+60.4%

Company

Next earnings (est.): Feb 23, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 913
Held by institutions: 72.7%
Auditor: Deloitte & Touche LLP
SEC CIK: 1350653

Advertisement
300 × 250

See a number that looks wrong?